Logo

microfluidics

Bioké Inks Distribution Agreements With Scale Biosciences, Atrandi Biosciences

The deals add to the Dutch distributor's single-cell sequencing and microfluidics technology offerings in the Netherlands, Belgium, and Luxembourg.

European 3DSecret Project to Deliver New Microfluidic Platform to Predict Cancer Metastasis
Premium

Sphere Fluidics is the sole commercial partner and has the right to commercialize any resulting technology.

Angle, BioView Partner to Develop Quantitative HER2 Assay Using Circulating Tumor Cells

The companies said recent developments in HER2-targeted therapies have created new commercial opportunities for a blood-based test.

Samplix Garners €10M in Funding From European Innovation Council

Copenhagen-based Samplix will use the accelerator investment to develop approaches for the functional characterization of single cells.

Atrandi Biosciences Raises $4.8M to Advance Commercialization of Single-Cell Microfluidics Tech

The company, formerly called Droplet Genomics, will apply the funds to establish a US customer support team and to advance commercialization of its droplet-based platforms.

Mar 23, 2023

Irish Diagnostics Firm Altratech Aims to Enter Molecular, POC Testing Space by Supplanting PCR
Premium

Mar 16, 2023

Integra Biosciences Acquires Miroculus

Feb 24, 2023

New Droplet-Based Single-Cell RNA-Seq Method Enables Transcriptome Profiling of Individual Synapses
Premium

Dec 16, 2022

KU Leuven-led Project Aims to Develop Mass PCR Testing Platform for Future Pandemics
Premium

Dec 8, 2022

New Standard BioTools Management Counting on Better Business Processes to Turn Firm Around
Premium

Nov 18, 2022

UCLA Team Uses Magnets, Microfluidics to Create Handheld Molecular Dx System
Premium

Oct 13, 2022

Standard BioTools Partner Ascendas Genomics Gets Chinese Approval for MDx Systems

Jun 17, 2022

EUA in Hand, MicroGEM Aims to Grow Market for 30-Minute RT-PCR System
Premium

May 11, 2022

Interpace Biosciences, Miroculus, Twist Bioscience Partner to Automate NGS Library Prep in Cancer Dx

May 5, 2022

Standard BioTools Q1 Revenues Fall 19 Percent

Mar 24, 2022

Volta Labs, Miroculus Independently Harness Electrowetting for Automated NGS Sample Prep
Premium

Mar 17, 2022

Volta Labs Raises $20M in Series A Financing Round

Jan 25, 2022

Droplet Genomics Debuts New Microfluidic Screening Platform, Touting Throughput, Flexibility
Premium

Jan 13, 2022

Florida Atlantic University Wins $1.3M NIH Grant to Develop Sample-to-Answer HIV Self-Test

Dec 16, 2021

Single-Cell Startup Nodexus Raises $30M in Series A Financing Round

Dec 14, 2021

Sphere Fluidics Plans New Applications for Single-Cell Isolation, Assay Platform
Premium

Oct 29, 2021

Qiagen, NeuMoDx Lose Patent Appeal in BD/HandyLab Dispute

Oct 7, 2021

Angle Readies for Clinical Testing as CTC Research Continues to Yield Biomarker Insights
Premium

Aug 26, 2021

Scienion, Cellenion Enter Exclusive Licensing Deal, Partnership With Pacific Northwest National Lab

Jul 28, 2021

Capio Biosciences, BioView to Explore Integration of Circulating Tumor Cell Technologies

Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.